Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Need outside expertise? Lack available staff? Want an objective perspective? Pharma Consulting will work with you to produce actionable, flexible solutions tailored to your needs. Our services will help you discover new business opportunities, reduce risks and make better decisions, faster.
We specialize in pharma portfolio management, commercial optimization and research and development strategy – whatever your business needs, we have competent experts to partner with you. And with access to best-in-class datasets, primary research capabilities, and experienced business analysts, you need look no further for a consulting partner.
You will receive customized research and analysis that transforms information on clinical trials, drugs and sites into actionable development plans, gain recommendations to capture the full commercial potential of a product, portfolio or market opportunity, and understand the value and associated risk/return for your drug development portfolio.
Our consultants leverage the data, resources and expertise of Informa's market leading intelligence sources to produce the most authoritative tailored solutions
We draw expertise from over 100 leading specialists
Customized solutions addressing business issues. We deliver insight and value to give you confidence in your strategic decisions
Serving big pharma, mid-tier, biotech, generics and medical device companies. We work globally and locally to support your business objectives
Citeline Analytics provides customized research and analysis that transforms information on pharmaceutical clinical trials, drugs and sites into actionable intelligence for your organization.
Pharma Consulting
By Pharma Intelligence 16 Dec 2016
The Issue Our client asked us to help support their CNS product portfolio strategy by helping to understand the clinical and commercial potential of the schizophrenia market
Pharma Consulting
16 Dec 2016
The Issue: Our client wished to understand the potential impact of the competitor’s drug going generic on their brand and whether there would be any spill-over effects.
Pharma Consulting
16 Dec 2016
The Issue: A global pharmaceutical company needed to assess the current and future competitive landscape of an early-stage analog drug to determine the possibilities of market entry and the viability of possible differentiation strategies to compete in the market.
Pharma Consulting
By Pharma Intelligence 01 Jan 2016
Issue A large biotech needed the correct analogs for follow-on biologics PTS in Oncology and Respiratory programs across a range of segments to assess the risk of their portfolio
Pharma Consulting
By Pharma Intelligence 01 Jan 2016
The Issue: The client was looking to develop a deeper understanding of the payer landscape in Europe and Japan as part of an overall market opportunity assessment
Boston
Timothy specializes in
+21 year(s) experience
New York
Ellen specializes in
+16 year(s) experience
How can we help you?
For a personal discussion, please email us your inquiry, so we can provide you the best possible customer service:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
